Pliant Therapeutics (PLRX)
(Real Time Quote from BATS)
$15.63 USD
+0.27 (1.76%)
Updated May 16, 2024 02:04 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.85 |
EPS Last Quarter | -0.78 |
Last EPS Surprise | -2.63% |
ABR | 1.14 |
Earnings ESP
|
0.39% |
---|---|
Current Year | -3.44 |
Next Year | -3.71 |
EPS (TTM) | -2.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.25M | 0.00M | 1.58M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.85 | -0.88 | -3.44 | -3.71 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -0.82 | -0.84 | -3.35 | -3.53 |
High Estimate | -0.80 | -0.81 | -3.20 | -3.40 |
Low Estimate | -0.93 | -1.01 | -3.80 | -4.45 |
Year ago EPS | -0.70 | -0.70 | NA | -3.44 |
Year over Year Growth Est. | -21.43% | -25.71% | NA | -8.08% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 3 |
Up Last 60 Days | 1 | 1 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 6 | 4 |
Down Last 60 Days | 4 | 4 | 6 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.85 | -0.88 | -3.44 | -3.71 |
7 Days Ago | -0.85 | -0.88 | -3.44 | -3.71 |
30 Days Ago | -0.79 | -0.83 | -3.27 | -3.54 |
60 Days Ago | -0.79 | -0.83 | -3.27 | -3.54 |
90 Days Ago | -0.81 | -0.83 | -3.50 | -3.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.85 | -0.87 | -3.44 | -3.71 |
Zacks Consensus Estimate | -0.85 | -0.88 | -3.44 | -3.71 |
Earnings ESP | 0.39% | 0.57% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.78 | NA | -0.70 | -0.70 | NA |
Estimate | -0.76 | NA | -0.78 | -0.73 | NA |
Difference | -0.02 | NA | 0.08 | 0.03 | 0.03 |
Surprise | -2.63% | NA | 10.26% | 4.11% | 3.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more